Hopeful of revolutionary
medical therapies using a patient's own cells, scientists rushed to
capitalize on the discovery by 2012 Nobel Laureate Shinya Yamanaka.
However, the process has remained slow and inefficient, and scientists
have had a difficult time discovering a genetic explanation of why this
should be.
In the Jan. 30 issue of the journal
Cell,
Yale School of Medicine researchers identified a major obstacle to
converting cells back to their youthful state -- the speed of the cell
cycle, or the time required for a cell to divide.
When the cell
cycle accelerates to a certain speed, the barriers that keep a cell's
fate on one path diminish. In such a state, cells are easily persuaded
to change their identity and become pluripotent, or capable of becoming
multiple cell types.
"One analogy may be that when temperature
increases to sufficient degrees, even a very hard piece of steel can be
malleable so that you can give it a new shape easily," said Shangqin
Guo, assistant professor of cell biology at the Yale Stem Cell Center
and lead author of the paper. "Once cells are cycling extremely fast,
they do not seem to face the same barriers to becoming pluripotent."
Guo's
team studied blood-forming cells, which when dividing undergo specific
changes in their cell cycle to produce new blood cells. Blood-forming
progenitor cells normally produce only new blood cells. However, the
introduction of Yamanaka factors sometimes -- but not always -- help
these blood-forming cells become other types of cells. The new report
finds that after this treatment blood-forming cells tend to become
pluripotent when the cell cycle is completed in eight hours or less, an
unusual speed for adult cells. Cells that cycle more slowly remain blood
cells.
"This discovery changes the way people think about how to
change cell fate and reveals that a basic 'house-keeping' function of a
cell, such as its cell cycle length, can actually have a major impact
on switching the fate of a cell," said Haifan Lin, director of the Yale
Stem Cell Center.
The study has other implications than
explaining the bottleneck in reprogramming that makes it difficult to
produce individualized pluripotent stem cells for research and therapy.
Shangqin Guo noted that many human diseases are associated with
abnormalities in establishing proper cell identity as well as
abnormalities in cell cycle behavior.
Video:
http://vimeo.com/59083655
No comments:
Post a Comment